Yooma News28 Apr 2021 15:48
TORONTO, April 28, 2021 /CNW/ - Yooma Wellness Inc. ("Yooma") (CSE: YOOM), an emerging marketer and distributor of cannabinoid and hemp-derived wellness products, is pleased to announce CBD food products from its MYO Plant Nutrition and Blossom brands have been added to the U.K. Food Standard Agency's novel foods list.
On February 13th, 2020 the FSA announced it would impose a deadline of March 31st, 2021 for companies to submit a novel food authorization application for CBD food products sold in the region. The process is meant to ensure the items meet legal standards, including on safety and content. After an initial review, MYO and Blossom's products have been granted validation to stay on sale in the U.K. market. Full authorization is expected within 9 months after a rigorous safety assessment. MYO Plant Nutrition and Blossom are part of a small number of CBD brands to be granted approval.
"This approval represents a significant milestone for the MYO and Blossom brands," commented Lorne Abony, Chairman of Yooma. "This is a meaningful evolutionary step for MYO and Blossom; one which creates a significant barrier to market entry."
"We're delighted that the U.K. FSA (Food Standards Agency) has included in their public list ten products from portfolio brands MYO Plant Nutrition and Blossom," said James Lawson Baker, Founder of MYO Plant Nutrition. "The validation cements our position as a leading and trusted U.K. and European supplier of branded ingestible CBD products."
MYO Plant Nutrition combines high-quality plant-based ingredients with carefully selected key active ingredients to form functional nutrition products including plant proteins, branched-chain amino acids ("BCAA's"), essential amino acids ("EAA's") and CBD oils. Its plant-based performance nutrition products are currently carried in the U.K.'s largest health and wellness retailer, Holland and Barrett. Blossom is a premium skincare brand that counts ingestible oils and teas as part of its product mix.